← FDA Drug Approvals (Drugs@FDA)

LENALIDOMIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HETERO LABS LTD V · Approved 2023-05-11

Drug application

FDA Application #

ANDA212414

Application type

Abbreviated New Drug Application (Generic)

Brand name

LENALIDOMIDE

Generic name

LENALIDOMIDE

Active ingredients

LENALIDOMIDE

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

HETERO LABS LTD V

Manufacturer

Camber Pharmaceuticals, Inc.

First approval

2023-05-11

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown